Drrx stock forecast.

Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ...Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...View the latest Lakeland Financial Corp. (LKFN) stock price, news, historical charts, analyst ratings and financial information from WSJ.Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to ...

Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.62

The Applied Uv stock price gained 9.13% on the last trading day (Friday, 1st Dec 2023), rising from $0.115 to $0.126. During the last trading day the stock fluctuated 17.43% from a day low at $0.111 to a day high of $0.130. The price has fallen in 6 of the last 10 days and is down by -13.45% for this period. Volume fell on the last day by -337 ...

The inventory’s buying and selling value of $2.58 and common value goal of $29.80 mirror the excessive potential of the main drug candidate – and indicate a 1,064% achieve subsequent yr. (be seen DRRX stock forecast)Real time Durect (DRRX) stock price quote, stock graph, news & analysis. Stock Price and Dividend Data for Durect Corp (DRRX), including dividend dates, dividend yield, company news, and key financial metrics.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median estimate represents a...

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.DRRX: anyone following this stock? It's had quite an amazing run. The OI on the 2.5 dollar jan calls is quite high (much higher than the corresponding puts), and there seems to be two catalysts around the corner with the adcom at Jan 16 as well as the data for Dur-928 due either by the end of this year or early Jan next year. The adcom was ...Doing some research is necessary before pulling the trigger on any penny stock. Following the recommendations from Wall Street pros can help in the due diligence process. Bearing this in mind, we used the TipRanks database to take a look at two penny stocks getting rave reviews from Oppenheimer analyst Francois Brisebois, with the firm’s …Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors […]DURECT has an Altman Z-Score of -16.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -16.45. Piotroski F-Score. 2. Detailed statistics for DURECT Corporation (DRRX) stock, including valuation metrics, financial numbers, share information and more.Get the latest Microvast Holdings Inc (MVST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.View the latest Durect Corp. (DRRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.... DURECT · Dutch Bros · D-Wave Quantum · DXC Technology Company · DXP Enterprises · Dyadic International · Dycom Industries · Dynagas LNG Partners LP · Dynatrace.DURECT Announces 1-for-10 Reverse Stock Split. CUPERTINO, Calif., Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX ), a biopharmaceutical company focused on developing epigenetic ...

Latest Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced

DSAC stock forecast for 2023 – 2027. Last updated: November 22, 2023. Are you interested in Duddell Street Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the DSAC stock price in …DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...Durect Stock Chart and Share Price Forecast, Short-Term "DRRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Durect Corp (DRRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...Dec 1, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00. Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ... Stock Price Forecast The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 34.50, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +984.91% increase from the last price of 3.18.

When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes.

Forecast . Price target. 19.38 0.00 0.00%. The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 4 analysts giving stock ratings to DRRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreBased on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialStock analysis for Durect Corp (DRRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.According to . 2 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $34.00, with the highest DRRX stock price forecast at $41.00 and the lowest DRRX stock price forecast at $27.00.Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to ...Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.DRRX Stock Price Forecast. The average stock forecast for DURECT Corp (DRRX) in the next 12 months is 30.40 USD. This price target corresponds to an upside of 10.83%. The range of stock forecasts for DRRX is 12.12 - 43.05 USD. …People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Their DRRX share price targets range from $27.00 to $41.00. On average, they expect the company's stock price to reach $34.25 in the next twelve months. This suggests a possible upside of 5,194.5% from the stock's current price. View analysts price targets for DRRX or view top-rated stocks among Wall Street analysts. DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the message is clear: AVDL is a Strong Buy ...Instagram:https://instagram. christie auctiontop forex trading platformaston martin stocksweb based futures trading platform On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trial quarters of valuebest mortgage lenders in charlotte nc DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.DRRX is a biopharmaceutical company that develops medicines based on its epigenetic regulator and pharmaceutical programs. The stock price forecast is $34.25, an increase of 1,275.50% from the latest price, according to 4 analysts. The company offers ALZET product line for research in mice, rats, and other laboratory animals. ttd share price Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.